Speaker illustration

Professor Gerd Hasenfuss

Georg-August University, Goettingen (Germany)

Member of:

European Society of Cardiology
Heart Failure Association

Gerd Hasenfuß is Professor of Internal Medicine and Cardiology and since 1998 Director of the Clinic of Cardiology and Pneumology at University Medical Center Göttingen, Germany, since 2001 Chair of Heart Center Göttingen, and since 2010 of Heart Research Center Göttingen. He is a specialist in heart failure pathophysiology and clinical treatment. His main research interests include calcium cycling, electrophysiology, and stem cell biology. Dr. Hasenfuß received his training in medicine at University of Freiburg from 1982 to 1988. From 1988 to 1990 he was Visiting Assistant Professor at Department Molecular Physiology and Biophysics, University of Burlington, Vermont, USA. 1993 to 1998 he was an Assistant Professor in Internal Medicine and Cardiology, University of Freiburg. From 2011 until 2019 he was appointed member of the Board of Directors of the DZHK (Deutsches Zentrum für Herz-Kreislaufforschung e.V.). Since 2012 he is Speaker of the CRC 1002 "Modulatory Units in Heart Failure".

Metabolism and cardiovascular diseases: completely inseparable

Event: ESC Congress 2023

Topic: Basic Science

Session type: Symposium

Thumbnail

Young Investigator Award Session

Event: HFA Winter Research Meeting on Translational Heart Failure 2023

Topic: Basic Science

Session type: Award Sessions

Thumbnail

Cellular effectiveness of drug therapies

Event: ESC Congress 2022

Topic: Drugs, Drug Targets

Session type: Moderated ePosters

Thumbnail

Basic mechanism of valvular heart disease

Event: ESC Congress 2019

Topic: Valvular Heart Disease

Session type: Moderated Posters

Thumbnail

Mechanisms behind intrinsic myocardial repair and regeneration

Event: ESC Congress 2019

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session type: Symposium

Thumbnail

Risk prediction in heart failure outcome

Event: ESC Congress 2019

Topic: Chronic Heart Failure

Session type: Advances in Science

Thumbnail

Positive inotropy - Still an approach we should go for?

Event: Heart Failure 2018

Topic: Signal Transduction, Mechanotransduction

Session type: Symposium

Thumbnail

Advanced heart failure: when drugs alone are not enough

Event: ESC Congress 2017

Topic: AHF - Non pharmacological treatment

Session type: Symposium

Thumbnail

New drugs in acute heart failure

Event: ESC Congress 2016

Topic: Pharmacologic therapy

Session type: Symposium

Thumbnail

Myocarditis: update 2016

Event: HEART FAILURE 2016

Topic: Myocarditis

Session type: Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb